Friday July 18, 2014

ABK Biomedical Receives $2.14M in funding

Posted in: News

BOYNECLARKE LLP congratulates ABK Biomedical Inc. on being awarded $2.14 Million from the Atlantic Canada Opportunities Agency (ACOA), under the Atlantic Innovation Fund (AIF).

Founded by interventional radiologist, Dr. Bob Abraham and materials scientists Dr. Daniel Boyd and Dr. Sharon Kehoe, ABK Biomedical Inc. is a research and development company pursuing development, production and sale of embolic agents and peripheral vascular delivery devices.  ABK innovates integrated devices to simplify clinical procedures performed by interventional radiologists, with the lead system OccluRad /OccluDel, targeting hypervascular tumours including uterine fibroids.  The AIF funding will support the development and commercialization of biomaterials that will simplify and enhance the delivery of chemotherapy and radiotherapy for cancer patients.

Congratulations to ABK Biomedical on your recent success!

Share This Post:

Recent Blog Posts

News | Monday April 6, 2020

Virtual Notarization

Posted in:

Do you need something signed by a notary or commissionaires of oaths? Our lawyers can help.

Read full article
News | Friday April 3, 2020

COVID-19 Update

Posted in:

Effective Monday, April 6, we are moving to a fully remote environment for all staff and lawyers. Our office will be closed. While working from home, we will continue to operate and serve our clients.

Read full article
News | Thursday March 26, 2020

AFCC's Guidelines For Parents Who Are Divorced/Separated and Sharing Custody of Children During the COVID-19 Pandemic

Posted in:

The Association of Family and Conciliation Courts has a new coronavirus resources and information page.

Read full article
News | Wednesday March 25, 2020

Notice: COVID-19 Update

Posted in:

Please note that our office is closed to clients and visitors. Our legal professionals, however, continue to operate.

Read full article